592
Views
10
CrossRef citations to date
0
Altmetric
Review

Renal Artery Stenosis in the Patient with Hypertension: Prevalence, Impact and Management

, & ORCID Icon
Pages 71-82 | Published online: 02 Jun 2020

References

  • Kalra P, Guo H, Kausz A, et al. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization and prognosis. Kidney Int. 2005;68(1):293–301. doi:10.1111/j.1523-1755.2005.00406.x15954920
  • Scoble J. The epidemiology and clinical manifestations of atherosclerotic renal disease In: Renal Vascular Disease. London, UK: WB Saunders Co, Ltd; 1996:303–314.
  • Payami B, Jafarizade M, Mousavi S, Sattari S, Nokhostin F. Prevalence and predictors of atherosclerotic renal artery stenosis in the hypertensive patients undergoing simultaneous coronary and renal angiography: a cross-sectional study. J Renal Inj Prev. 2016;5(1):34–38. doi:10.15171/jrip.2016.0827069966
  • Schreiber M, Pohl M, Novick A. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am. 1984;11(3):383–392.6464247
  • Wheatley K, Ives N, Gray R, et al. Revascularization versus Medical Therapy for Renal-Artery Stenosis. N Engl J Med. 2009;361:1953–1962.19907042
  • Bax L, Mali W, Buskens E, et al. The benefit of stent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by atherosclerotic ostial stenosis of the renal artery. the star-study: rationale and study design. J Nephrol. 2003;16(6):807–812.14736007
  • Cooper C, Murphy T, Cutlip D, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014;370(1):13–22. doi:10.1056/NEJMoa131075324245566
  • Lederman R, Mendelsohn F, Santos R, Phillips H, Stack R, Crowley J. Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J. 2001;142(2):314–323. doi:10.1067/mhj.2001.11695811479472
  • Mitchell J, Subramanian R, White C, et al. Predicting Blood pressure improvement in hypertensive patients after renal artery stent placement: renal fractional flow reserve. Catheter Cardiovasc Interv. 2007;69(5):685–689. doi:10.1002/ccd.2109517351955
  • Leesar M, Varma J, Shapira A, et al. Prediction of hypertension improvement after stenting of renal artery stenosis: comparative accuracy of translesional pressure gradients, intravascular ultrasound, and angiography. J Am Coll Cardiol. 2009;53(25):2363–2371. doi:10.1016/j.jacc.2009.03.03119539148
  • Mangiacapra F, Trana C, Sarno G, et al. Translesional pressure gradients to predict blood pressure response after renal artery stenting in patients with renovascular hypertension. Circ Cardiovasc Interv. 2010;3(6):537–542. doi:10.1161/CIRCINTERVENTIONS.110.95770421078879
  • Silva J, Chan A, White C, et al. Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis. Circulation. 2005;111(3):328–333. doi:10.1161/01.CIR.0000153271.77341.9F15655135
  • Sun D, Eirin A, Ebrahimi B, Textor S, Lerman A, Lerman L. Early atherosclerosis aggravates renal microvascular loss and fibrosis in swine renal artery stenosis. J Am Soc Hypertens. 2016;10(4):325–335. doi:10.1016/j.jash.2016.01.01926879682
  • Zhang X, Krier J, Carrascal C, et al. Low- energy shockwave therapy improves ischemic kidney microcirculation. JASN. 2016;27(12):3715–3724. doi:10.1681/ASN.201506070427297945
  • Cooper E, Xie Y, Nguyen H, et al. Early rapid decline in kidney function in medically managed patients with atherosclerotic renal artery stenosis. J Am Heart Assoc. 2019;8(11). doi:10.1161/JAHA.119.012366
  • Zierler R, Bergelin R, Isaacson J, Strandness D. Natural history of atherosclerotic renal artery stenosis: a prospective study with duplex ultrasonography. J Vasc Surg. 1994;19(2):250–257. doi:10.1016/S0741-5214(94)70100-88114186
  • Caps M, Zierler R, Polissar N, et al. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int. 1998;53(3):735–742. doi:10.1046/j.1523-1755.1998.00805.x9507221
  • Chabova V, Schirger A, Stanson A, McKusick M, Textor S. Outcomes of atherosclerotic renal artery stenosis managed without revascularization. Mayo Clin Proc. 2000;75(5):437–444. doi:10.1016/S0025-6196(11)64210-910807070
  • Watson P, Hadjipetrou P, Cox S, Piemonte T, Eisenhauer A. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation. 2000;102(14):1671–1677. doi:10.1161/01.CIR.102.14.167111015346
  • Kalra P, Chrysochou C, Green D, et al. The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease. Catheter Cardiovasc Interv. 2010;75(1):1–10. doi:10.1002/ccd.2229019937777
  • Goldblatt H, Lynch J, Hanzal R, Summerville W. Studies on experimental hypertension: i. the production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med. 1934;59(3):347–379. doi:10.1084/jem.59.3.34719870251
  • Cohen J, Townsend R. Use of renin-angiotensin system blockade in patients with renal artery stenosis. CJASN. 2014;9(7):1149–1152. doi:10.2215/CJN.0424041424903389
  • Hocher B, George I, Rebstock J, et al. Endothelin system- dependent cardiac remodeling in renovascular hypertension. Hypertension. 1999;33(3):816–822. doi:10.1161/01.HYP.33.3.81610082493
  • Herrmann S, Textor S. Current concepts in the treatment of renovascular hypertension. Am J Hypertens. 2018;31(2):139–149. doi:10.1093/ajh/hpx15428985335
  • Van der Niepen P, Rossignol P, Lengele J, et al. Renal artery stenosis in patients with resistant hypertension: stent it or not? Curr Hypertens Rep. 2017;19(5). doi:10.1007/s11906-017-0703-8
  • Rocha-Singh K, Eisenhauer A, Textor S, et al. Atherosclerotic peripheral vascular disease symposium ii: interventional for renal artery disease. Circulation. 2008;118(25):2873–2878. doi:10.1161/CIRCULATIONAHA.108.19117819106410
  • Klein A, Jaff M, Gray B, et al. SCAI appropriate use criteria for peripheral arterial interventions: an update. Catheter Cardiovasc Interv. 2017;90(4):E90–E110. doi:10.1002/ccd.2714128489285
  • Hirsch A, Haskal Z, Hertzer N, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the american association for vascular surgery/society for vascular surgery, society for cardiovascular angiography and interventions, society for vascular medicine and biology, society of interventional radiology, and the acc/aha task force on practice guidelines. Circulation. 2006;113(11):e463–e654. doi:10.1161/CIRCULATIONAHA.106.17452616549646
  • Messerli F, Bangalore S, Makani H, et al. Flash pulmonary edema and bilateral renal artery stenosis: the Pickering syndrome. Eur Heart J. 2011;32(18):2231–2235. doi:10.1093/eurheartj/ehr05621406441
  • Khosla S, White C, Collins T, Jenkins J, Shaw D, Ramee S. Effects of renal artery stent implantation in patients with renovascular hypertension presenting with unstable angina or congestive heart failure. Am J Cardiol. 1997;80(3):363–366. doi:10.1016/S0002-9149(97)00368-89264441
  • Garcia-Donaire J, Alcazar J. Ischemic nephropathy: detection and therapeutic intervention. Kidney Int. 2005;68(99):S131–S136. doi:10.1111/j.1523-1755.2005.09924.x
  • Schaberle W, Leyerer L, Schierling W, et al. Ultrasound diagnostics of renal artery stenosis. Gefasschirurgie. 2016;21(S1):4–13. doi:10.1007/s00772-015-0060-327034579
  • Rountas C, Vlychou M, Liakopoulos V, et al. Imaging modalities for renal artery stenosis in suspected renovascular hypertension: prospective intraindividual comparison of color doppler US, CT angiography, GD-enhanced MR angiography, and digital substraction angiography. Ren Fail. 2007;29(3):295–302. doi:10.1080/0886022060116630517497443
  • McLaughlin K, Jardine A, Moss J. Renal artery stenosis. BMJ. 2000;320(7242):1124–1127. doi:10.1136/bmj.320.7242.112410775226
  • Lim S, Chrysochou C, Buckley D, Kalra P, Sourbron S. Prediction and assessment of responses to renal artery revascularization with dynamic contrast-enhanced magnetic resonance imaging: a pilot study. Am J Physiol Renal Physiol. 2013;305(5):F672–F678. doi:10.1152/ajprenal.00007.201323804449
  • Ebrahimi B, Textor S, Lerman L. Renal Relevant radiology: renal functional magnetic resonance imaging. Clin J Am Soc Nephrol. 2014;9(2):395–405. doi:10.2215/CJN.0290031324370767
  • Waksman R, Kitabata H, Prati F, Albertucci M, Mintz G. Intravascular ultrasound versus optical coherence tomography guidance. J Am Coll Cardiol. 2013;67(17):S32–S40. doi:10.1016/j.jacc.2013.08.709
  • Naghi J, Palakodeti S, Ang L, Reeves R, Patel M, Mahmud E. Renal Frame Count: A Measure Of Renal Flow That Predicts Success Of Renal Artery Stenting In Hypertensive Patients. Catheter Cardiovasc Interv. 2015;86(2):304–309. doi:10.1002/ccd.2594626198066
  • Kotiliar C, Inserra F, Forcada P. Are plasma renin activity and aldosterone levels useful as a screening test to differentiate between unilateral and bilateral renal artery stenosis in hypertensive patients? J Hypertens. 2010;28(3):594–601. doi:10.1097/HJH.0b013e32833487d420104188
  • Stratigis S, Stylianou K, Kyriazis P, et al. Renal artery stenting for atherosclerotic renal artery stenosis identified in patients with coronary artery disease: does captopril renal scintigraphy predict outcomes? J Clin Hypertens. 2018;20(2):373–381. doi:10.1111/jch.13160
  • Taylor A, Fletcher J, Nally J, et al. Procedure guideline for diagnosis of renovascular hypertension. society of nuclear medicine. J Nucl Med. 1998;39(7):1297–1302.9669414
  • Badila E, Tintea E. How to manage renovascular hypertension. An article from the e-journal of the ESC council for cardiology practice. ESC. 2014;13:8–9.
  • Muneer K, Nair A. Angiotensin-converting enzyme inhibitors and receptor blockers in heart failure and chronic kidney disease- Demystifying controversies. Indian Heart J. 2017;69(3):371–374. doi:10.1016/j.ihj.2016.08.00728648436
  • Silva V, Martin L, Franco R, et al. Pleiotropic effects of statins may improve outcomes in atherosclerotic renovascular disease. Am J Hypertens. 2008;21(10):1163–1168. doi:10.1038/ajh.2008.24918670414
  • Berger J, Krantz M, Kittelson J, Hiatt W. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease. a meta-analysis of randomized trials. JAMA. 2009;301(18):1909–1919. doi:10.1001/jama.2009.62319436018
  • Jaff M, Bates M, Sullivan T, et al. Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial. Catheter Cardiovasc Interv. 2012;80(3):343–350. doi:10.1002/ccd.2444922511402
  • Marcantoni C, Zanoli L, Rastelli S, et al. Stenting of renal artery stenosis in coronary artery disease (ras-cad) study: a prospective, randomized trial. J Nephrol. 2009;22(1):13–16.19229814
  • Kawarada O, Kume T, Nakamura S, et al. Cardiac function response to stenting in atherosclerotic renal artery disease with and without heart failure: results from the Carmel study. ESC Heart Fail. 2019;6(2):319–327. doi:10.1002/ehf2.1239130614643
  • Scarpioni R, Michieletti E, Cristinelli L, et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). J Nephrol. 2005;18(4):423–428.16245247
  • Rossi G, Seccia T, Miotto D, et al. The medical and endovascular treatment of atherosclerotic renal artery stenosis (METRAS) study: rationale and study design. J Hum Hypertens. 2012;26(8):507–516. doi:10.1038/jhh.2011.6221716318
  • Bailey S, Beckman J, Dao T, et al. ACC/AHA/SCAI/SIR/SVM 2018 appropriate use criteria for peripheral artery intervention: a report of the american college of cardiology appropriate use criteria task force, american heart association, society for cardiovascular angiography and interventions, society of interventional radiology, and society for vascular medicine. J Am Coll Cardiol. 2019;73(2):214–237. doi:10.1016/j.jacc.2018.10.00230573393
  • Gray B, Olin J, Childs M, Sullivan T, Bacharach M. Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure. Vasc Med. 2002;7(4):275–279. doi:10.1191/1358863x02vm456oa12710843
  • Sapoval M, Zahringer M, Pattynama P, et al. Low-profile stent system for treatment of atherosclerotic renal artery stenosis: the GREAT trial. J Vasc Interv Radiol. 2005;16(9):1195–1202. doi:10.1097/01.RVI.0000171765.67665.D316151060
  • Blum U, Krumme B, Flugel P, et al. Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty. N Engl J Med. 1997;336(7):459–465. doi:10.1056/NEJM1997021333607029017938
  • Henry M, Amor M, Henry I, et al. Stents in the treatment of renal artery stenosis: long-term follow-up. J Endovasc Surg. 1999;6(1):42–51. doi:10.1583/1074-6218(1999)006<0042:SITTOR>2.0.CO;210088889
  • Ruzsa Z, Toth K, Jambrik Z, et al. Transradial access for renal artery intervention. Interv Med Appl Sci. 2014;6(3):97–103. doi:10.1556/IMAS.6.2014.3.125243074
  • Feldman R, Wargovich T, Bittl J. No-touch technique for reducing aortic wall trauma during renal artery stenting. Catheter Cardiovasc Interv. 1999;46(2):245–248. doi:10.1002/(SICI)1522-726X(199902)46:2<245::AID-CCD27>3.0.CO;2-V10348553
  • Haller S, Adlakha S, Reed G, et al. Platelet activation in patients with atherosclerotic renal artery stenosis undergoing stent revascularization. Clinical Journal of the American Society of Nephrology. 2011;6(9):2185–2191. doi:10.2215/CJN.0314041121817131
  • Campbell J, Stone P, Bates M. Technical discussion of diagnostic angiography and intervention of atherosclerotic renal artery stenosis. Semin Vasc Surg. 2013;26(4):150–160. doi:10.1053/j.semvascsurg.2014.06.00225220320
  • Mohler E, Gornik H, Gerhard-Herman M, et al. ACCF/ACR/AIUM/ASE/ASN/ICAVL/SCAI/SCCT/SIR/SVM/SVS 2012 appropriate use criteria for peripheral vascular ultrasound and physiological testing part i: arterial ultrasound and physiological testing: a report of the american college of cardiology foundation appropriate use criteria task force, american college of radiology, american institute of ultrasound in medicine, american society of echocardiography, american society of nephrology, intersocietal commission for the accreditation of vascular laboratories, society for cardiovascular angiography and interventions, society of cardiovascular computed tomography, society for interventional radiology, society for vascular medicine, and society for vascular surgery. J Am Coll Cardiol. 2012;60(3):242–276. doi:10.1016/j.jacc.2012.02.00922694840
  • Chi Y, White C, Thornton S, Milani R. Ultrasound velocity criteria for renal in-stent restenosis. J Vasc Surg. 2009;50(1):119–123. doi:10.1016/j.jvs.2008.12.06619233590
  • Ritchie J, Kalra P. ASTRAL and beyond: who is appropriate to consider for renal artery revascularization? Vasc Dis Manage. 2011;8:E12–E20.
  • Eirin A, Textor S, Lerman L. Novel therapeutic strategies for renovascular disease. Curr Opin Nephrol Hypertens. 2019;28(4):383–389. doi:10.1097/MNH.000000000000051331045658